MKS Instruments Reports Second Quarter 2020 Financial Results
- Quarterly revenue of
$544 million , up 15% year-over-year - Quarterly Semiconductor Market revenue of
$321 million , up 50% year-over-year, led by record revenue in our Power Solutions business - Quarterly non-GAAP net earnings per diluted share of
$1.62 , up 49% year-over-year - Quarterly GAAP net income per diluted share of
$1.33 - Record quarterly operating cash flow of
$139 million and free cash flow of$118 million
“We are pleased with our strong financial performance, particularly given the global factory and supply chain disruptions we faced entering the quarter. This is a validation of our world class operational execution and our unique offering of critical enabling technologies. Robust year-over-year Semiconductor Market revenue growth of 50% was driven by broad-based demand across our portfolio – in particular for our Power Solutions business, where we delivered record revenue led by demand from leading-edge semiconductor applications,” said John TC Lee, President and Chief Executive Officer.
“The sequential improvement in our second quarter non-GAAP operating margin is a testament to our ability to drive operating leverage in our financial model. We will continue to manage our business with a focus on sustainable and profitable growth,” said
Third Quarter 2020 Outlook
Based on current business levels, the Company expects revenue in the third quarter of 2020 could range from
Conference Call Details
A conference call with management will be held on
About MKS Instruments
Use of Non-GAAP Financial Results
This press release includes measures that are not in accordance with
Selected GAAP and Non-GAAP Financial Measures
(In millions, except per share data)
Second Quarter 2020 Financial Results
Q2 2020 | Q1 2020 | |||||
Net revenues | $ | 544 | $ | 536 | ||
GAAP Financial Measures | ||||||
Operating margin | 18.5 | % | 16.8 | % | ||
Net income | $ | 74 | $ | 69 | ||
Diluted EPS | $ | 1.33 | $ | 1.25 | ||
Non-GAAP Financial Measures | ||||||
Operating margin | 21.6 | % | 20.5 | % | ||
Net earnings | $ | 89 | $ | 85 | ||
Diluted EPS | $ | 1.62 | $ | 1.54 | ||
Net revenues in the second quarter of 2020 were
Net income in the second quarter of 2020 was
Net income in the second quarter of 2020 included restructuring and other costs of
Non-GAAP net earnings, which exclude special charges and credits, were
Additional Financial Information
At
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and 21E of the Securities Exchange Act of 1934 regarding the future financial performance, business prospects and growth of
Company Contact:
Vice President, Investor Relations
Telephone: (978) 557-5180
Email: david.ryzhik@mksinst.com
MKS Instruments, Inc. | ||||||||||||||||
Unaudited Consolidated Statements of Operations | ||||||||||||||||
(In millions, except per share data) | ||||||||||||||||
Quarter Ended | Six Months Ended | |||||||||||||||
2020 | 2019 | 2020 | 2020 | 2019 | ||||||||||||
Net revenues: | ||||||||||||||||
Products | $ | 473.0 | $ | 401.3 | $ | 461.2 | $ | 934.2 | $ | 798.7 | ||||||
Services | 71.3 | 72.8 | 74.5 | 145.8 | 139.0 | |||||||||||
Total net revenues | 544.3 | 474.1 | 535.7 | 1,080.0 | 937.7 | |||||||||||
Cost of revenues: | ||||||||||||||||
Products | 258.0 | 226.2 | 256.1 | 514.1 | 455.9 | |||||||||||
Services | 40.0 | 36.9 | 40.0 | 80.0 | 72.6 | |||||||||||
Total cost of revenues | 298.0 | 263.1 | 296.1 | 594.1 | 528.5 | |||||||||||
Gross profit | 246.3 | 211.0 | 239.6 | 485.9 | 409.2 | |||||||||||
Research and development | 42.8 | 41.9 | 42.4 | 85.2 | 80.8 | |||||||||||
Selling, general and administrative | 86.1 | 83.2 | 87.2 | 173.3 | 165.7 | |||||||||||
Acquisition and integration costs | 0.7 | 3.2 | 2.2 | 2.9 | 33.4 | |||||||||||
Restructuring and other | 3.3 | 1.2 | 0.4 | 3.7 | 3.2 | |||||||||||
Amortization of intangible assets | 13.8 | 17.6 | 16.3 | 30.1 | 33.3 | |||||||||||
Asset impairment | — | — | 1.2 | 1.2 | — | |||||||||||
COVID-19 related net credits | (1.2 | ) | — | — | (1.2 | ) | — | |||||||||
Fees and expenses related to Term Loan Facility | — | — | — | — | 5.8 | |||||||||||
Income from operations | 100.8 | 63.9 | 89.9 | 190.7 | 87.0 | |||||||||||
Interest income | 0.3 | 1.4 | 0.7 | 1.0 | 3.1 | |||||||||||
Interest expense | 7.2 | 12.7 | 8.9 | 16.1 | 21.8 | |||||||||||
Other expense, net | 1.5 | 0.8 | 0.4 | 1.9 | 1.1 | |||||||||||
Income before income taxes | 92.4 | 51.8 | 81.3 | 173.7 | 67.2 | |||||||||||
Provision for income taxes | 18.7 | 14.1 | 12.2 | 30.9 | 17.0 | |||||||||||
Net income | $ | 73.7 | $ | 37.7 | $ | 69.1 | $ | 142.8 | $ | 50.2 | ||||||
Net income per share: | ||||||||||||||||
Basic | $ | 1.34 | $ | 0.69 | $ | 1.26 | $ | 2.60 | $ | 0.92 | ||||||
Diluted | $ | 1.33 | $ | 0.69 | $ | 1.25 | $ | 2.58 | $ | 0.91 | ||||||
Cash dividends per common share | $ | 0.20 | $ | 0.20 | $ | 0.20 | $ | 0.40 | $ | 0.40 | ||||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 55.1 | 54.8 | 54.9 | 55.0 | 54.5 | |||||||||||
Diluted | 55.3 | 55.1 | 55.2 | 55.3 | 55.0 | |||||||||||
Unaudited Consolidated Balance Sheet | ||||||||||||||||
(In millions) | ||||||||||||||||
2020 | 2019 | |||||||||||||||
ASSETS | ||||||||||||||||
Cash and cash equivalents | $ | 428.9 | $ | 414.6 | ||||||||||||
Short-term investments | 178.1 | 109.4 | ||||||||||||||
Trade accounts receivable, net | 381.1 | 341.1 | ||||||||||||||
Inventories | 490.2 | 462.1 | ||||||||||||||
Other current assets | 91.5 | 106.3 | ||||||||||||||
Total current assets | 1,569.8 | 1,433.5 | ||||||||||||||
Property, plant and equipment, net | 248.4 | 241.9 | ||||||||||||||
Right-of-use asset | 174.3 | 64.5 | ||||||||||||||
1,058.1 | 1,058.5 | |||||||||||||||
Intangible assets, net | 534.4 | 564.6 | ||||||||||||||
Long-term investments | 6.0 | 5.8 | ||||||||||||||
Other assets | 40.1 | 47.5 | ||||||||||||||
Total assets | $ | 3,631.1 | $ | 3,416.3 | ||||||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||
Short-term debt | $ | 11.3 | $ | 12.1 | ||||||||||||
Accounts payable | 105.0 | 88.4 | ||||||||||||||
Accrued compensation | 104.3 | 100.9 | ||||||||||||||
Income taxes payable | 16.0 | 15.4 | ||||||||||||||
Lease liability | 16.7 | 20.6 | ||||||||||||||
Deferred revenue and customer advances | 28.7 | 21.5 | ||||||||||||||
Other current liabilities | 69.6 | 58.8 | ||||||||||||||
Total current liabilities | 351.6 | 317.7 | ||||||||||||||
Long-term debt, net | 818.6 | 871.7 | ||||||||||||||
Non-current deferred taxes | 71.0 | 72.4 | ||||||||||||||
Non-current accrued compensation | 43.6 | 43.9 | ||||||||||||||
Non-current lease liability | 162.3 | 44.8 | ||||||||||||||
Other liabilities | 57.4 | 42.5 | ||||||||||||||
Total liabilities | 1,504.5 | 1,393.0 | ||||||||||||||
Stockholders' equity: | ||||||||||||||||
Common stock | 0.1 | 0.1 | ||||||||||||||
Additional paid-in capital | 858.7 | 864.3 | ||||||||||||||
Retained earnings | 1,302.0 | 1,181.2 | ||||||||||||||
Accumulated other comprehensive loss | (34.2 | ) | (22.3 | ) | ||||||||||||
Total stockholders' equity | 2,126.6 | 2,023.3 | ||||||||||||||
Total liabilities and stockholders' equity | $ | 3,631.1 | $ | 3,416.3 | ||||||||||||
MKS Instruments, Inc. | ||||||||||||||||
Unaudited Consolidated Statements of Cash Flows | ||||||||||||||||
(In millions) | ||||||||||||||||
Quarter Ended | Six Months Ended | |||||||||||||||
2020 | 2019 | 2020 | 2020 | 2019 | ||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net income | $ | 73.7 | $ | 37.7 | $ | 69.1 | $ | 142.8 | $ | 50.2 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||
Depreciation and amortization | 24.1 | 27.4 | 28.4 | 52.5 | 52.7 | |||||||||||
Amortization of inventory step-up adjustment to fair value | — | 2.5 | — | — | 7.6 | |||||||||||
Amortization of debt issuance costs and original issue discount | 0.5 | 1.8 | 1.1 | 1.6 | 2.9 | |||||||||||
Stock-based compensation | 6.8 | 6.9 | 8.5 | 15.3 | 34.8 | |||||||||||
Provision for excess and obsolete inventory | 6.7 | 7.0 | 6.2 | 12.9 | 12.1 | |||||||||||
(Recovery) provision for doubtful accounts | — | (0.2 | ) | 0.2 | 0.2 | (0.7 | ) | |||||||||
Deferred income taxes | 2.8 | (0.2 | ) | 0.6 | 3.4 | (2.6 | ) | |||||||||
Asset impairment | — | — | 1.2 | 1.2 | — | |||||||||||
Other | 0.4 | 0.8 | (0.1 | ) | 0.3 | 0.9 | ||||||||||
Changes in operating assets and liabilities | 24.0 | (6.2 | ) | (40.3 | ) | (16.3 | ) | (51.3 | ) | |||||||
Net cash provided by operating activities | 139.0 | 77.5 | 74.9 | 213.9 | 106.6 | |||||||||||
Cash flows (used in) provided by investing activities: | ||||||||||||||||
Acquisition of business, net of cash acquired | — | — | — | — | (988.6 | ) | ||||||||||
Purchases of investments | (164.3 | ) | (73.7 | ) | (30.2 | ) | (194.5 | ) | (117.9 | ) | ||||||
Maturities of investments | 47.8 | 21.7 | 49.5 | 97.3 | 40.4 | |||||||||||
Sales of investments | — | 3.2 | 28.7 | 28.7 | 157.7 | |||||||||||
Purchases of property, plant and equipment | (20.9 | ) | (13.7 | ) | (10.0 | ) | (30.9 | ) | (28.2 | ) | ||||||
Net cash (used in) provided by investing activities | (137.4 | ) | (62.5 | ) | 38.0 | (99.4 | ) | (936.6 | ) | |||||||
Cash flows (used in) provided by financing activities: | ||||||||||||||||
Net proceeds from short and long-term borrowings | 4.6 | 2.3 | 12.1 | 16.7 | 640.9 | |||||||||||
Payments of short-term borrowings | (7.6 | ) | (1.8 | ) | (9.9 | ) | (17.5 | ) | (1.9 | ) | ||||||
Payments of long-term borrowings | (2.2 | ) | (51.6 | ) | (52.3 | ) | (54.5 | ) | (51.7 | ) | ||||||
Dividend payments | (11.0 | ) | (10.9 | ) | (11.0 | ) | (22.0 | ) | (21.7 | ) | ||||||
Net payments related to employee stock awards | (0.5 | ) | (2.0 | ) | (20.4 | ) | (20.9 | ) | (11.0 | ) | ||||||
Net cash (used in) provided by financing activities | (16.7 | ) | (64.0 | ) | (81.5 | ) | (98.2 | ) | 554.6 | |||||||
Effect of exchange rate changes on cash and cash equivalents | 2.0 | (2.1 | ) | (4.0 | ) | (2.0 | ) | (2.0 | ) | |||||||
(Decrease) increase in cash and cash equivalents | (13.1 | ) | (51.1 | ) | 27.4 | 14.3 | (277.4 | ) | ||||||||
Cash and cash equivalents at beginning of period | 442.0 | 418.0 | 414.6 | 414.6 | 644.3 | |||||||||||
Cash and cash equivalents at end of period | $ | 428.9 | $ | 366.9 | $ | 442.0 | $ | 428.9 | $ | 366.9 | ||||||
The following supplemental Non-GAAP earnings information is presented to aid in understanding MKS’ operating results:
MKS Instruments, Inc. | ||||||||||||||||
Schedule Reconciling Selected Non-GAAP Financial Measures | ||||||||||||||||
(In millions, except per share data) | ||||||||||||||||
Quarter Ended | Six Months Ended | |||||||||||||||
2020 | 2019 | 2020 | 2020 | 2019 | ||||||||||||
Net income | $ | 73.7 | $ | 37.7 | $ | 69.1 | $ | 142.8 | $ | 50.2 | ||||||
COVID-19 related net credits (Note 1) | (0.9 | ) | — | — | (0.9 | ) | — | |||||||||
Acquisition inventory step-up (Note 2) | — | 2.5 | — | — | 7.6 | |||||||||||
Acquisition and integration costs (Note 3) | 0.7 | 3.2 | 2.2 | 2.9 | 33.4 | |||||||||||
Amortization of debt issuance costs (Note 4) | 0.2 | 1.3 | 0.9 | 1.1 | 1.9 | |||||||||||
Restructuring and other (Note 5) | 3.3 | 1.2 | 0.4 | 3.7 | 3.2 | |||||||||||
Amortization of intangible assets | 13.8 | 17.6 | 16.3 | 30.1 | 33.3 | |||||||||||
Asset impairment (Note 6) | — | — | 1.2 | 1.2 | — | |||||||||||
Fees and expenses related to Term Loan (Note 7) | — | — | — | — | 5.8 | |||||||||||
Windfall tax benefit on stock-based compensation (Note 8) | (1.4 | ) | (0.8 | ) | (0.9 | ) | (2.3 | ) | (2.1 | ) | ||||||
Deferred tax asset write-off (Note 9) | 3.5 | — | — | 3.5 | — | |||||||||||
Tax reform adjustments (Note 10) | — | 2.7 | — | — | 2.7 | |||||||||||
Tax effect of Non-GAAP adjustments (Note 17) | (3.6 | ) | (5.6 | ) | (4.3 | ) | (8.0 | ) | (14.8 | ) | ||||||
Non-GAAP net earnings (Note 11) | $ | 89.3 | $ | 59.8 | $ | 84.9 | $ | 174.1 | $ | 121.2 | ||||||
Non-GAAP net earnings per diluted share (Note 11) | $ | 1.62 | $ | 1.09 | $ | 1.54 | $ | 3.15 | $ | 2.20 | ||||||
Weighted average diluted shares outstanding | 55.3 | 55.1 | 55.2 | 55.3 | 55.0 | |||||||||||
Net cash provided by operating activities | $ | 139.0 | $ | 77.5 | $ | 74.9 | $ | 213.9 | $ | 106.6 | ||||||
Purchases of property, plant and equipment | (20.9 | ) | (13.7 | ) | (10.0 | ) | (30.9 | ) | (28.2 | ) | ||||||
Free cash flow | $ | 118.1 | $ | 63.8 | $ | 64.9 | $ | 183.0 | $ | 78.4 | ||||||
MKS Instruments, Inc. | ||||||||||||||||
Schedule Reconciling Selected Non-GAAP Financial Measures | ||||||||||||||||
(In millions) | ||||||||||||||||
Quarter Ended | Six Months Ended | |||||||||||||||
2020 | 2019 | 2020 | 2020 | 2019 | ||||||||||||
Gross profit | $ | 246.3 | $ | 211.0 | $ | 239.6 | $ | 485.9 | $ | 409.2 | ||||||
COVID-19 related net costs (Note 1) | 0.3 | — | — | 0.3 | — | |||||||||||
Acquisition inventory step-up (Note 2) | — | 2.5 | — | — | 7.6 | |||||||||||
Non-GAAP gross profit (Note 12) | $ | 246.6 | $ | 213.5 | $ | 239.6 | $ | 486.2 | $ | 416.8 | ||||||
Non-GAAP gross margin (Note 12) | 45.3 | % | 45.0 | % | 44.7 | % | 45.0 | % | 44.4 | % | ||||||
Operating expenses | $ | 145.5 | $ | 147.1 | $ | 149.7 | $ | 295.2 | $ | 322.2 | ||||||
Acquisition and integration costs (Note 3) | 0.7 | 3.2 | 2.2 | 2.9 | 33.4 | |||||||||||
Restructuring and other (Note 5) | 3.3 | 1.2 | 0.4 | 3.7 | 3.2 | |||||||||||
Amortization of intangible assets | 13.8 | 17.6 | 16.3 | 30.1 | 33.3 | |||||||||||
Asset impairment (Note 6) | — | — | 1.2 | 1.2 | — | |||||||||||
COVID-19 related net credits (Note 1) | (1.2 | ) | — | — | (1.2 | ) | — | |||||||||
Fees and expenses related to Term Loan (Note 7) | — | — | — | — | 5.8 | |||||||||||
Non-GAAP operating expenses (Note 13) | $ | 128.9 | $ | 125.1 | $ | 129.6 | $ | 258.5 | $ | 246.5 | ||||||
Income from operations | $ | 100.8 | $ | 63.9 | $ | 89.9 | $ | 190.7 | $ | 87.0 | ||||||
COVID-19 related net credits (Note 1) | (0.9 | ) | — | — | (0.9 | ) | — | |||||||||
Acquisition inventory step-up (Note 2) | — | 2.5 | — | — | 7.6 | |||||||||||
Acquisition and integration costs (Note 3) | 0.7 | 3.2 | 2.2 | 2.9 | 33.4 | |||||||||||
Restructuring and other (Note 5) | 3.3 | 1.2 | 0.4 | 3.7 | 3.2 | |||||||||||
Amortization of intangible assets | 13.8 | 17.6 | 16.3 | 30.1 | 33.3 | |||||||||||
Asset impairment (Note 6) | — | — | 1.2 | 1.2 | — | |||||||||||
Fees and expenses related to Term Loan (Note 7) | — | — | — | — | 5.8 | |||||||||||
Non-GAAP income from operations (Note 14) | $ | 117.7 | $ | 88.4 | $ | 110.0 | $ | 227.7 | $ | 170.3 | ||||||
Non-GAAP operating margin (Note 14) | 21.6 | % | 18.6 | % | 20.5 | % | 21.1 | % | 18.2 | % | ||||||
Interest expense, net | $ | 6.9 | $ | 11.3 | $ | 8.2 | $ | 15.1 | $ | 18.7 | ||||||
Amortization of debt issuance costs (Note 4) | 0.2 | 1.3 | 0.9 | 1.1 | 1.9 | |||||||||||
Non-GAAP interest expense, net | $ | 6.7 | $ | 10.0 | $ | 7.3 | $ | 14.0 | $ | 16.8 | ||||||
Net income | $ | 73.7 | $ | 37.7 | $ | 69.1 | $ | 142.8 | $ | 50.2 | ||||||
Interest expense, net | 6.9 | 11.3 | 8.2 | 15.1 | 18.7 | |||||||||||
Provision for income taxes | 18.7 | 14.1 | 12.2 | 30.9 | 17.0 | |||||||||||
Depreciation | 10.3 | 9.9 | 12.1 | 22.4 | 19.3 | |||||||||||
Amortization | 13.8 | 17.6 | 16.3 | 30.1 | 33.3 | |||||||||||
EBITDA (Note 15) | $ | 123.4 | $ | 90.6 | $ | 117.9 | $ | 241.3 | $ | 138.5 | ||||||
Stock-based compensation | 6.7 | 5.9 | 8.0 | 14.7 | 15.2 | |||||||||||
COVID-19 related net credits (Note 1) | (0.9 | ) | — | — | (0.9 | ) | — | |||||||||
Acquisition inventory step-up (Note 2) | — | 2.5 | — | — | 7.6 | |||||||||||
Acquisition and integration costs (Note 3) | 0.7 | 3.2 | 2.2 | 2.9 | 33.4 | |||||||||||
Restructuring and other (Note 5) | 3.3 | 1.2 | 0.4 | 3.7 | 3.2 | |||||||||||
Asset impairment (Note 6) | — | — | 1.2 | 1.2 | — | |||||||||||
Fees and expenses related to Term Loan (Note 7) | — | — | — | — | 5.8 | |||||||||||
Other adjustments | — | — | — | — | 3.4 | |||||||||||
Adjusted EBITDA (Note 16) | $ | 133.2 | $ | 103.4 | $ | 129.7 | $ | 262.9 | $ | 207.1 | ||||||
Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate |
||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||
Three Months Ended June 30, 2020 | Three Months Ended |
|||||||||||||||||||||
Income Before | Provision (benefit) | Effective | Income Before | Provision (benefit) | Effective | |||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | Income Taxes | for Income Taxes | Tax Rate | |||||||||||||||||
GAAP | $ | 92.4 | $ | 18.7 | 20.2 | % | $ | 51.8 | $ | 14.1 | 27.2 | % | ||||||||||
Adjustments: | ||||||||||||||||||||||
Acquisition and integration costs (Note 3) | 0.7 | — | 3.2 | — | ||||||||||||||||||
Acquisition inventory step-up (Note 2) | — | — | 2.5 | — | ||||||||||||||||||
Amortization of debt issuance costs (Note 4) | 0.2 | — | 1.3 | — | ||||||||||||||||||
Restructuring and other (Note 5) | 3.3 | — | 1.2 | — | ||||||||||||||||||
Amortization of intangible assets | 13.8 | — | 17.6 | — | ||||||||||||||||||
COVID-19 related net credits (Note 1) | (0.9 | ) | — | — | — | |||||||||||||||||
Windfall tax benefit on stock-based compensation (Note 8) | — | 1.4 | — | 0.8 | ||||||||||||||||||
Deferred tax asset write-off (Note 9) | — | (3.5 | ) | — | — | |||||||||||||||||
Tax reform adjustments (Note 10) | — | — | — | (2.7 | ) | |||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 17) | — | 3.6 | — | 5.6 | ||||||||||||||||||
Non-GAAP | $ | 109.5 | $ | 20.2 | 18.5 | % | $ | 77.6 | $ | 17.8 | 22.9 | % | ||||||||||
Three Months Ended |
||||||||||||||||||||||
Income Before | Provision | Effective | ||||||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | ||||||||||||||||||||
GAAP | $ | 81.3 | $ | 12.2 | 15.0 | % | ||||||||||||||||
Adjustments: | ||||||||||||||||||||||
Acquisition and integration costs (Note 3) | 2.2 | — | ||||||||||||||||||||
Amortization of debt issuance costs (Note 4) | 0.9 | — | ||||||||||||||||||||
Restructuring and other (Note 5) | 0.4 | — | ||||||||||||||||||||
Amortization of intangible assets | 16.3 | — | ||||||||||||||||||||
Asset impairment (Note 6) | 1.2 | — | ||||||||||||||||||||
Windfall tax benefit on stock-based compensation (Note 8) | — | 0.9 | ||||||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 17) | — | 4.3 | ||||||||||||||||||||
Non-GAAP | $ | 102.3 | $ | 17.4 | 17.0 | % | ||||||||||||||||
MKS Instruments, Inc. | ||||||||||||||||||||||
Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate | ||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||
Six Months Ended |
Six Months Ended |
|||||||||||||||||||||
Income Before | Provision (benefit) | Effective | Income Before | Provision (benefit) | Effective | |||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | Income Taxes | for Income Taxes | Tax Rate | |||||||||||||||||
GAAP | $ | 173.7 | $ | 30.9 | 17.8 | % | $ | 67.2 | $ | 17.0 | 25.3 | % | ||||||||||
Adjustments: | ||||||||||||||||||||||
Acquisition and integration costs (Note 3) | 2.9 | — | 33.4 | — | ||||||||||||||||||
Acquisition inventory step-up (Note 2) | — | — | 7.6 | — | ||||||||||||||||||
Amortization of debt issuance costs (Note 4) | 1.1 | — | 1.9 | — | ||||||||||||||||||
Restructuring and other (Note 5) | 3.7 | — | 3.2 | — | ||||||||||||||||||
Amortization of intangible assets | 30.1 | — | 33.3 | — | ||||||||||||||||||
Asset impairment (Note 6) | 1.2 | — | — | — | ||||||||||||||||||
COVID-19 related net credits (Note 1) | (0.9 | ) | — | — | — | |||||||||||||||||
Fees and expenses related to Term Loan (Note 7) | — | — | 5.8 | — | ||||||||||||||||||
Windfall tax benefit on stock-based compensation (Note 8) | — | 2.3 | — | 2.1 | ||||||||||||||||||
Deferred tax asset write-off (Note 9) | — | (3.5 | ) | — | — | |||||||||||||||||
Tax reform adjustments (Note 10) | — | — | — | (2.7 |
) | |||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 17) | — | 8.0 | — | 14.8 | ||||||||||||||||||
Non-GAAP | $ | 211.8 | $ | 37.7 | 17.8 | % |
$ | 152.4 | $ | 31.2 | 20.5 | % | ||||||||||
Schedule Reconciling Selected Non-GAAP Financial Measures – Q3’20 Guidance | |||||||||||||||
(In millions, except per share data) | |||||||||||||||
Three Months Ending |
|||||||||||||||
Low Guidance | High Guidance | ||||||||||||||
$ Amount | $ Per Share | $ Amount | $ Per Share | ||||||||||||
GAAP net income | $ | 71.8 | $ | 1.30 | $ | 93.2 | $ | 1.68 | |||||||
Amortization of intangible assets | 12.6 | 0.23 | 12.6 | 0.23 | |||||||||||
Deferred financing costs | 0.2 | — | 0.2 | — | |||||||||||
Acquisition and integration costs | 0.4 | 0.01 | 0.4 | 0.01 | |||||||||||
Restructuring and other costs | 6.1 | 0.11 | 6.1 | 0.11 | |||||||||||
Tax effect of Non-GAAP adjustments (Note 17) | (5.1 | ) | (0.09 | ) | (4.5 | ) | (0.08 | ) | |||||||
Non-GAAP net earnings | $ | 86.0 | 1.55 | $ | 108.0 | $ | 1.95 | ||||||||
Estimated weighted average diluted shares | 55.4 | 55.4 | |||||||||||||
Three Months Ending |
|||||||||||||||
Low Guidance | High Guidance | ||||||||||||||
$ Amount |
Percentage | $ Amount | Percentage | ||||||||||||
GAAP gross profit and margin | $ | 236.1 | 44.1 | % | $ | 269.9 | 46.2 | % | |||||||
Restructuring and other costs | 1.9 | 0.4 | % | 1.9 | 0.3 | % | |||||||||
Non-GAAP gross profit and margin | $ | 238.0 | 44.5 | % | $ | 271.8 | 46.5 | % | |||||||
Three Months Ending |
|||||||||||||||
Low Guidance | High Guidance | ||||||||||||||
$ Amount |
$ Amount |
||||||||||||||
GAAP operating expenses | $ | 143.2 | $ | 151.2 | |||||||||||
Acquisition and integration costs | (0.4 | ) | (0.4 | ) | |||||||||||
Restructuring and other costs | (4.2 | ) | (4.2 | ) | |||||||||||
Amortization of intangible assets | (12.6 | ) | (12.6 | ) | |||||||||||
Non-GAAP operating expenses | $ | 126.0 | $ | 134.0 | |||||||||||
Three Months Ending |
|||||||||||||||
Low Guidance | High Guidance | ||||||||||||||
$ Amount | Percentage | $ Amount | Percentage | ||||||||||||
GAAP operating income and margin | $ | 92.9 | 17.3 | % | $ | 118.7 | 20.2 | % | |||||||
Acquisition and integration costs | 0.4 | 0.1 | % | 0.4 | 0.1 | % | |||||||||
Restructuring and other costs | 6.1 | 1.1 | % | 6.1 | 1.0 | % | |||||||||
Amortization of intangible assets | 12.6 | 2.4 | % | 12.6 | 2.2 | % | |||||||||
Non-GAAP operating income and margin | $ | 112.0 | 20.9 | % | $ | 137.8 | 23.5 | % | |||||||
Three Months Ending |
|||||||||||||||
Guidance | |||||||||||||||
$ Amount |
|||||||||||||||
GAAP interest expense, net | $ | 6.3 | |||||||||||||
Deferred financing costs | (0.2 | ) | |||||||||||||
Non-GAAP interest expense, net | $ | 6.1 | |||||||||||||
Notes on Our Non-GAAP Financial Information
Non-GAAP financial measures adjust GAAP financial measures for the items listed below. These Non-GAAP measures should be viewed in addition to, and not as a substitute for, MKS' reported GAAP results, and may be different from Non-GAAP measures used by other companies. In addition, these Non-GAAP measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results.
Note 1: During the three and six months ended
Note 2: Cost of revenues during the three and six months ended
Note 3: Acquisition and integration costs were primarily related to our acquisition of ESI which closed on
Note 4: We recorded additional interest expense related to the amortization of debt issuance costs related to our Term Loan Credit Agreement and our ABL Credit Agreement.
Note 5: Restructuring and other costs during the three and six months ended
Note 6: During the six months ended
Note 7: We recorded fees and expenses during the six months ended
Note 8: We recorded windfall tax benefits on the vesting of stock-based compensation.
Note 9: We recorded a write-off of a deferred tax asset related to foreign net operating losses.
Note 10: We recorded tax adjustments during the three and six months ended
Note 11: Non-GAAP net earnings and Non-GAAP net earnings per diluted share amounts exclude net credits related to the COVID-19 pandemic, amortization of the step-up of inventory to fair value, acquisition and integration costs, amortization of debt issuance costs, restructuring and other costs, amortization of intangible assets, asset impairments, fees and expenses related to repricings of, and amendments to, our secured term loan, windfall tax adjustments related to stock compensation expense, a deferred tax write-off, tax reform adjustments and the related tax effect of these adjustments to reflect the expected full year effective tax rate in the related period.
Note 12: The Non-GAAP gross profit amount and Non-GAAP gross margin exclude net costs related to the COVID-19 pandemic and amortization of the step-up of inventory to fair value.
Note 13: Non-GAAP operating expenses exclude acquisition and integration costs, restructuring and other costs, amortization of intangible assets, asset impairments, net credits related to the COVID-19 pandemic and fees and expenses related to repricings of our secured term loan.
Note 14: Non-GAAP income from operations and Non-GAAP operating margin percentages exclude net credits related to the COVID-19 pandemic, amortization of the step-up of inventory to fair value, acquisition and integration costs, restructuring and other costs, amortization of intangible assets, an asset impairment and fees and expenses related to repricings of our secured term loan.
Note 15: EBITDA excludes net interest, income taxes, depreciation and amortization of intangible assets.
Note 16: Adjusted EBITDA excludes from EBITDA, stock-based compensation, acquisition and integration costs, net credits related to the COVID-19 pandemic, amortization of the step-up of inventory to fair value, restructuring and other costs, an asset impairment and fees and expenses related to repricings and amendments of our secured term loan.
Note 17: Non-GAAP adjustments are tax effected at applicable statutory rates resulting in a difference between the GAAP and Non-GAAP tax rates. For the three months ending
Source: MKS Instruments, Inc.